Pricing
No subscriptions.
No automatic dose increases.
Most patients spend approximately $120–180 per month depending on dose.
What We Offer
We offer medically supervised weight loss using GLP-1 medications. Treatment is individualized, dosing is adjusted based on response, and there are no subscriptions or automatic dose increases.
Semaglutide Pricing
(In-clinic starter dose injections are available for patients who prefer to try the medication before committing to a vial)
Typical starting dose is 0.25 mg once weekly.
Starter Option
2.5 mg vial – $269
Designed for initial dosing (0.25mg/ week) = 10 weeks
Standard Option
7.5 mg vial – $349
If dose is larger is 0.5 mg / week = 15 weeks
Estimated cost: ~$115–175/month
Best Value ⭐
15 mg vial – $449
Best option for slower titration and long-term use
Estimated cost: ~$110–150/month
Common dose after titration is 1-1.5mg weekly if needed.
The goal is to remain on the lowest effective dose.
Tirzepatide Options
(In-clinic starter dose injections are available for patients who prefer to try the medication before committing to a vial)
Typical starting dose:2.5 mg once weekly.
Starter Option
20 mg vial – $339
Designed for initial dosing ( 2.5 mg/week) = 8 weeks
Lasts about 2 months at starting dose
Estimated cost: ~$170/month
Standard Option
40 mg vial – $469
If weekly dose is larger @ (4 mg/week) = 10 weeks
Best Value ⭐
60 mg vial – $499
Best option for slower titration and long-term use
Lasts about 4 months
Estimated cost: ~$80–85/monthCommon dose after titration is 5–7 mg weekly if needed.
The goal is to remain on the lowest effective dose.
FAQ: Do I have to buy a full vial to start?
No. If you’d prefer to try the medication before committing to a vial, we offer in-clinic starter dose injections. This allows you to experience how your body responds to the medication before moving forward. In-clinic starter injections are available for an additional $25 per injection and are administered under medical supervision. If you do well, you can then transition to a take-home vial.
